Related references
Note: Only part of the references are listed.Inhibition of Protein Phosphatase 2A Radiosensitizes Pancreatic Cancers by Modulating CDC25C/CDK1 and Homologous Recombination Repair
Dongping Wei et al.
CLINICAL CANCER RESEARCH (2013)
Poly(ADP-ribose) Polymerase 1 Is a Key Regulator of Estrogen Receptor α-dependent Gene Transcription
Fengxiao Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Development of Therapeutic Combinations Targeting Major Cancer Signaling Pathways
Timothy A. Yap et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Targeted Radiosensitization of ETS Fusion-Positive Prostate Cancer through PARP1 Inhibition
Sumin Han et al.
NEOPLASIA (2013)
Beyond DNA repairs additional functions of PARP-1 in cancer
Alice N. Weaver et al.
FRONTIERS IN ONCOLOGY (2013)
Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment
Lenka Oplustilova et al.
CELL CYCLE (2012)
Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative
Apostolia-Maria Tsimberidou et al.
CLINICAL CANCER RESEARCH (2012)
Modern Outcomes of Inflammatory Breast Cancer
Sana Rehman et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27
Eleftherios P. Mamounas et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The Androgen Receptor in Breast Tissues: Growth Inhibitor, Tumor Suppressor, Oncogene?
T. E. Hickey et al.
MOLECULAR ENDOCRINOLOGY (2012)
Dual Roles of PARP-1 Promote Cancer Growth and Progression
Matthew J. Schiewer et al.
CANCER DISCOVERY (2012)
Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer
J. Chad Brenner et al.
CANCER CELL (2011)
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
Karen A. Gelmon et al.
LANCET ONCOLOGY (2011)
Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines
Antoinette Hollestelle et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Pre-clinical and clinical evaluation of PARP inhibitors as tumour-specific radiosensitisers
C. Powell et al.
CANCER TREATMENT REVIEWS (2010)
Translating cancer research into targeted therapeutics
J. S. de Bono et al.
NATURE (2010)
Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer
Eunice L. Kwak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Enhancing Radiotherapy Through a Greater Understanding of Homologous Recombination
Christopher A. Barker et al.
SEMINARS IN RADIATION ONCOLOGY (2010)
Low-risk susceptibility alleles in 40 human breast cancer cell lines
Muhammad Riaz et al.
BMC CANCER (2009)
POLY(ADP-RIBOSE) POLYMERASE-1 AND DNA-DEPENDENT PROTEIN KINASE HAVE EQUIVALENT ROLES IN DOUBLE STRAND BREAK REPAIR FOLLOWING IONIZING RADIATION
Jody Mitchell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Utility of DNA Repair Protein Foci for the Detection of Putative BRCA1 Pathway Defects in Breast Cancer Biopsies
Henning Willers et al.
MOLECULAR CANCER RESEARCH (2009)
A synthetic lethal therapeutic approach: Poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair
Alan Ashworth
JOURNAL OF CLINICAL ONCOLOGY (2008)
Inhibition of poly (ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models
Jeffrey M. Albert et al.
CLINICAL CANCER RESEARCH (2007)
ABT-888, an orallyactive poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models
Cherrie K. Donawho et al.
CLINICAL CANCER RESEARCH (2007)
RAD18 and poly(ADP-ribose) polymerase independently suppress the access of nonhomologous end joining to double-strand breaks and facilitate homologous recombination-mediated repair
Alihossein Saberi et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition
Nuala McCabe et al.
CANCER RESEARCH (2006)
A topoisomerase IIβ-mediated dsDNA break required for regulated transcription
BG Ju et al.
SCIENCE (2006)
BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants
F Elstrodt et al.
CANCER RESEARCH (2006)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Risks and benefits of phase 1 oncology trials, 1991 through 2002
E Horstmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
PARP-1, PARP-2, and the cellular response to low doses of ionizing radiation
A Chalmers et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Role of cell cycle in mediating sensitivity to radiotherapy
TM Pawlik et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Hallmarks of 'BRCAness' in sporadic cancers
N Turner et al.
NATURE REVIEWS CANCER (2004)
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia
SG O'Brien et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation
TA Buchholz et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Base excision repair is impaired in mammalian cells lacking poly(ADP-ribose) polymerase-1
F Dantzer et al.
BIOCHEMISTRY (2000)
Share Paper
